Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 290 publications
MAGIC Composite Score Predicts Outcomes of Second-Line Therapy for Acute GVHD.
Journal: medRxiv : the preprint server for health sciences
Published: July 29, 2026
Pediatric-inspired therapy and blinatumomab consolidation improve outcomes in young adults with Philadelphia-like acute lymphoblastic leukemia.
Journal: Haematologica
Published: June 24, 2026
Allogeneic heamatopoietic stem cell transplant in patients with refractory T-cell large granular lymphocytic leukaemia: A single-centre experience.
Journal: British journal of haematology
Published: June 03, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.
Journal: American journal of hematology
Published: May 29, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.
Journal: Blood immunology & cellular therapy
Published: May 15, 2026
Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: May 01, 2026
The 2026 definition of ruxolitinib refractoriness in severe acute GVHD.
Journal: Bone marrow transplantation
Published: April 03, 2026
A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm.
Journal: Journal of hematology & oncology
Published: March 24, 2026
The Influence of Race/Ethnicity and Social Vulnerability on Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant in Older (≥60 Years) Adults.
Journal: Transplantation and cellular therapy
Published: February 27, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: January 30, 2026
The Effect of Belumosudil on the Therapeutic Drug Levels of Tacrolimus and Sirolimus in Allogeneic Hematopoietic Transplantation.
Journal: Transplantation and cellular therapy
Published: January 30, 2026
Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: January 08, 2026
Last Updated: 09/26/2026